Ex Parte BatemanDownload PDFPatent Trial and Appeal BoardMar 29, 201711886587 (P.T.A.B. Mar. 29, 2017) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 0119/0070 8170 EXAMINER LOUIS, LATOYA M ART UNIT PAPER NUMBER 3771 MAIL DATE DELIVERY MODE 11/886,587 09/18/2007 135866 7590 03/29/2017 LAW OFFICE OF LOUIS WOO 717 NORTH FAYETTE STREET ALEXANDRIA, VA 22314 Timothy Bateman 03/29/2017 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte TIMOTHY BATEMAN Appeal 2015-007300 Application 11/886,5871 Technology Center 3700 Before TONI R. SCHEINER, DONALD E. ADAMS, and ERICA A. FRANKLIN, Administrative Patent Judges. ADAMS, Administrative Patent Judge. DECISION ON APPEAL This Appeal2 under 35 U.S.C. § 134(a) involves claims 9—22 (App. Br. 5).3 Examiner entered rejections under 35 U.S.C. § 103(a). We have jurisdiction under 35 U.S.C. § 6(b). We REVERSE. 1 Appellant identifies the real party in interest as “Smiths Group PLC” (App. Br. 3). 2 This is the second Appeal of this Application {see App. Br. 4). A Decision in the first Appeal, Appeal 2012-002172, affirming rejections of then pending claims 1, 2, and 4—8 was entered December 11, 2013. 3 “Claims 1-8 have been cancelled” (App. Br. 5). Appeal 2015-007300 Application 11/886,587 STATEMENT OF THE CASE Appellant discloses “tracheostomy tube assemblies of the kind including an outer, tubular shaft having a bore extending along it for passage of gas and an introducer inserted within the shaft, the assembly having a passage extending along its length for receiving an elongate guide member” (Spec. 1). Independent claims 9 and 16 are representative and reproduced below: 9. A tracheostomy tube assembly comprising: an outer, tubular shaft having a bore extending along it for passage of gas, a distal end and a radially inwardly projecting collar at the inner circumferential wall of the shaft; and an introducer inserted within the shaft to provide a tapered tip to the assembly adapted to be used to introduce the assembly through tracheal tissue of a patient during insertion of the assembly into the trachea of the patient, the introducer having a distal portion that is adapted to extend beyond the distal end of the shaft, the distal portion of the introducer being tapered towards a distal opening of a passage extending along the length of the introducer adapted to receive an elongate guide member, the introducer further having an annular shoulder projecting outwardly from its outer circumferential wall; wherein when the introducer is fully inserted into the shaft, the tapered distal portion of the introducer extends beyond the distal end of the shaft to provide a projecting, tapering nose that forms the tapered tip for the assembly for introducing and guiding the assembly through the tracheal tissue during insertion to the trachea; wherein one end of the elongate guide member is threaded through the distal opening of the introducer to the passage through the introducer so that the introducer is guided by and can slide along the elongate guide member, and another end of the elongate member is adapted to be located through an opening at the neck of the patient into the trachea of the patient; 2 Appeal 2015-007300 Application 11/886,587 wherein the radially projecting collar at the shaft and the annular shoulder at the introducer are engaged with each other to prevent rearward displacement of the shaft along the introducer as first the tapered distal portion of the introducer and then the shaft are guided by the elongate guide member into the trachea of the patient; and wherein after the shaft is properly located in the trachea of the patient, the introducer is removed rearwardly from the shaft so that the bore of the shaft is free to provide a gas passage to the trachea. (App. Br. 27.) Claims 10-15 depend from claim 9 (App. Br. 27—28). 16. A tracheostomy tube assembly comprising a shaft having a distal end and a bore extending along the shaft, an introducer matingly fitted into the bore with a tapered distal portion extending beyond the distal end of the shaft toward a distal opening at the introducer that opens into a passage that extends along the length of the introducer, the opening dimensioned to allow one end of an elongate member to be threaded therethrough into the passage so that the introducer can guidedly slide along the elongate member, the tapered distal portion of the introducer including a tapering nose adapted to act as a tip for the assembly to assist in introducing the assembly though tracheal tissue of a patient and the inserting of the shaft into the trachea of the patient after another end of the elongate guide member is inserted into the trachea of the patient, a radially inwardly projecting collar at the shaft and an outwardly projecting annular shoulder at the introducer engage to each other to cause the shaft to follow the movement of the introducer when the assembly is being guided by the elongate member into the trachea of the patient, the introducer being removable rearwardly from the shaft so that the bore of the shaft is opened to provide a gas passage to the trachea after the shaft is properly located in the trachea of the patient. {Id. at 28.) Claims 17—22 depend from claim 16 (App. Br. 29). 3 Appeal 2015-007300 Application 11/886,587 The claims stand rejected as follows: Claims 9—11, 13—18, and 20-22 stand rejected under 35 U.S.C. § 103(a) as unpatentable over the combination of Crandall,4 Shelden,5 and Weinstein.6 Claims 12 and 19 stand rejected under 35 U.S.C. § 103(a) as unpatentable over the combination of Crandall, Shelden, Weinstein, and Toye.7 Claims 9—11, 13, 16—18, and 20 stand rejected under 35 U.S.C. § 103(a) as unpatentable over the combination of Miles8 and Crandall. Claims 12 and 19 stand rejected under 35 U.S.C. § 103(a) as unpatentable over the combination of Miles, Crandall, and Toye. Claims 14 and 21 stand rejected under 35 U.S.C. § 103(a) as unpatentable over the combination of Miles, Crandall, and Theis.9 Claims 15 and 22 stand rejected under 35 U.S.C. § 103(a) as unpatentable over the combination of Miles, Crandall, and Weinstein. ISSUE Does the preponderance of evidence relied upon by Examiner support a conclusion of obviousness? 4 Crandall et al., US 4,315,505, issued Feb. 16, 1982 5 Shelden et al., US 2,991,787, issued July 11, 1961. 6 Weinstein, US 5,217,005, issued June 8, 1993. 7 Toye, US 6,382,209 Bl, issued May 7, 2002. 8 Miles et al., US 5,188,100, issued Feb. 23, 1993. 9 Theis et al., US 5,443,064, issued Aug. 22, 1995. 4 Appeal 2015-007300 Application 11/886,587 FACTUAL FINDINGS (FF) FF 1. Crandall “relates to tracheostomy tubes having an outer cannula and a removable inner cannula, and, in particular, to a tracheostomy tube having a disposable inner cannula” (Crandall 1:11—14). FF 2. Crandall’s Figure 1 is reproduced below: 36 “FIG. 1 is a perspective view of [Crandall’s] tracheostomy tube [] shown completely assembled” (Crandall 3:30-31; see generally Ans. 2—3). 5 Appeal 2015-007300 Application 11/886,587 FF 3. Crandall’s Figure 2 is reproduced below: .36 FIG 2 “FIG. 2 is a partial perspective view of [Crandall’s] tracheostomy tube with the inner cannula partially removed” (Crandall 3:32—33; see generally Ans. 2-3). FF 4. Crandall’s Figure 3 is reproduced below: “FIG. 3 is a partial sectional view taken through the distal end of the inner and outer cannulae” of Crandall’s tracheostomy tube (Crandall 3:34—35; see generally Ans. 3). 6 Appeal 2015-007300 Application 11/886,587 FF 5. Crandall discloses a “cylindrical, arcuate outer cannula 12 [] comprised of a distal end 16 for insertion into the trachea of the patient through an opening in the neck and a proximal end 18 remaining outside the trachea” (Crandall 3:45—49). FF 6. Crandall discloses an “inner cannula 14 [] inserted into the bore 26 of the outer cannula 12,” wherein the inner cannula 14 runs the entire length of the outer cannula 12 so that its distal tip 38 is flush with or slightly beyond the tapered necked-down portion 40 of the distal end 16 of the outer cannula 12 and the connector 28 is securely releasably attached to the proximal end 18 of the outer cannula 12. Formed in the inner cannula 14 is a passageway 37 which communicates with the opening 36 in the connector 28 to permit air to flow into the trachea. (Crandall 4:1—2 and 12—21; see generally Ans. 2—3.) FF 7. Crandall discloses that “a raised annular section 42” is “[ljocated just behind the tip 38 of the inner cannula 14,” wherein the raised annular section 42 is comprised of, from front to rear, a tapered, forwardly facing sealing surface 44, a non-tapered surface 46, and a tapered rearwardly facing surface 48. The sealing surface 44 is ffustro- conical in shape and engages the interior surface 50 of the necked-down portion 40 on the distal end 16 of the outer cannula 12 to form a tight air seal between the outer cannula 12 and inner cannula 14. This sealing surface 44 is sufficiently tapered so that at least one portion has an outer diameter which is greater than the inside diameter of the opening 52 of the outer cannula 12. (Crandall 4:22—36; see generally Ans. 2—3.) FF 8. Crandall discloses that the engagement between the inner cannula 14 and the outer cannula 12 [] serves as a stop device to prevent the tip 38 of the 7 Appeal 2015-007300 Application 11/886,587 inner cannula 14 from extending substantially beyond the very end 54 of the outer cannula 12. Moreover, the sloping interior surface 50 of the necked-down portion 40 of the outer cannula 12 cooperates to form this stop device since it presents a large, relatively rigid obstacle to the raised portion 42 on the inner cannula 14 which prohibits substantial protrusion of the tip 38. Furthermore, the location and length of the sealing surface 44 on the inner cannula 14 and the size of opening 52 on the outer cannula 12, which together form the air seal and stop devices of [Crandall’s] invention, are such that the tip 38 will be flush with the end 54 of the outer cannula if the interior surface 50 contacts the sealing surface 44 near its lower edge. If, on the other hand, the interior surface 50 contacts the upper edge of the sealing surface 44, the tip 38 will extend only slightly, e.g. about 0.050 inches, beyond the end 54 of the outer cannula. Thus, the stop device of [CrandalFs] invention advantageously regulates the position of the tip 38 within this narrow range, thereby compensating for variations in overall length among the present inner cannulae. (Crandall 4:47—5:2; see generally Ans. 2—3.) FF 9. CrandalFs “inner cannula 14 [] is easily attached to and removed from the outer cannula 12 with exertion of little or no longitudinal force, thereby preventing pain and discomfort to the patient” (Crandall 7:23—26). FF 10. Examiner finds that Crandall fails to suggest a tracheostomy tube assembly that comprises an inner cannula that is tapered at the distal end or an assembly that “includes an elongate guide member extending and threaded along the assembly such that the introducer can slide along the elongate member while a distal end of the elongate member extends into the trachea” (Ans. 3 and 4). FF 11. Shelden relates to surgical instruments and has particular reference to an instrument frequently designated a tracheotome or tracheotomy instrument which consists of an arcuate tube containing a knife - 8 Appeal 2015-007300 Application 11/886,587 like insert which can be injected into the throat or trachea to make it possible for a person to breathe under conditions where the upper portion of the throat might be stopped for any reason. (Shelden 1:11-18.) FF 12. Shelden’s Figure 6 is reproduced below: “FIGURE 6 is a longitudinal sectional view of [Shelden’s] tube with a removable insert or inner cannula applied therein” (Shelden 2:56—57). FF 13. Shelden’s Figure 9 is reproduced below: “FIGURE 9 is a perspective view of one of [Shelden’s] removable inner cannulae” (Shelden 2:61—62). 9 Appeal 2015-007300 Application 11/886,587 FF 14. Shelden discloses that “[o]nce inserted into the trachea [], [Shelden’s] tube 30 occupies the position shown in [Shelden’s] FIGURE 6. While so located an inner canula or disposable tube 75 may be inserted. . . . [T]he inner cannula [75] consists of a tubular portion 76 and an integral flanged portion 77,” wherein end 78 conforms to the inwardly depressed beveled interior of the tube 30 at the end 32. The length of the tubular portion is such that the beveled end 78 is substantially flush with the edge of the beveled end 32 of the tube when the flanged portion 77 lies against the bottom of the plate 36. The flanged portion fixes the position of the inner cannula when in position within the tube and also facilitates grasping the inner cannula for removal when replacement is needed. (Shelden 4:53—56 and 63—74; see Ans. 3 (Shelden discloses “that the distal end of the inner cannula is tapered”).) FF 15. Weinstein discloses the use of a guidewire “to assist in guiding [a] dilator [] and tube [] into [a] trachea” (Weinstein 4:14—17; see Ans. 4). FF 16. Examiner relies on Toye to disclose “an extremely flexible ultra- thinned wall tracheal tube [] such that it cannot support its own weight when supported at one end” (Ans. 5, citing Toye 4:60-62, 5:20—22, and 6:3—7). FF 17. Miles relates, inter alia, “to a tracheostomy kit including [] an obturator and the method of replacing a tracheostomy tube using the obturator and guide tube of [Miles’] invention” (Miles 1:6—13). 10 Appeal 2015-007300 Application 11/886,587 FF 18. Miles’ Figure 1 is reproduced below: FIG. f M “FIG. 1 is a schematic representative rear view of a tracheostomy tube with the specially constructed obturator of [Miles’] invention and a guide tube in place for use in accordance with and as part of the present invention” (Miles 3:31-35). FF 19. Miles’ Figure 3 is reproduced below: “FIG. 3 is a longitudinal cross-section of the obturator of [Miles’] invention” (Miles 3:39-40). 11 Appeal 2015-007300 Application 11/886,587 FF 20. Miles’ obturator 12 is substantially cylindrical and is made of a plastic material sufficiently flexible to permit it to easily assume the shape of the curved tracheostomy tube 20. The distal tip 18 of the obturator 12 is rounded or olive-tipped. At the proximal end of the obturator 12, there is disposed a flange 17. (Miles 3:59-65.) FF 21. Miles discloses that [t]he length of the obturator 12 is specifically selected so that when inserted into the tracheostomy tube 20 such that the flange 17 of the obturator 12 abuts the flange 16 of the tracheostomy tube 20 [] the rounded tip 18 will extend from the distal end of the tube 20. Thus, the rounded tip 18 of the obturator functions as an atraumatic guide tip to the distal end of the tracheostomy tube and serves to guide the tube and prevent tracheal damage which might otherwise be caused by the distal edges of the tracheostomy tube 20. (Miles 3:66-4:8.) FF 22. Miles’ obturator 12 has a longitudinal opening 15 centrally disposed therethrough. The central opening is large enough to allow a guide tube 14 [] to pass therethrough. The guide tube 14 and the central opening 15 must be sized so that the obturator 12 can easily slide over the guide tube 14 when the guide tube 14 is passed through the central opening 15. (Miles 4:9-15.) FF 23. Miles discloses a procedure [] for replacing a tracheostomy tube which is already in place on a patient, is made safe, and expedient by means of the apparatus of [Miles’] invention. When the tracheostomy tube 20 is in place in the patient with the cuff 30 inflated so as to seal the trachea, a guide tube 14 is fed through the tracheostomy tube 20 to be removed. The tube 14 is fed far enough to leave a good length of the guide tube 14 in the 12 Appeal 2015-007300 Application 11/886,587 trachea when the tracheostomy tube 20 is removed. The cuff 30 is then deflated with an appropriate syringe. The tracheostomy tube 20 is then removed over the guide tube 14 leaving the guide tube 14 in place in the trachea to serve as a guide to the existing opening to the trachea. An obturator 12 is inserted within a new tracheostomy tube 20 such that obturator flange 17 abuts tracheostomy tube flange 16 and the rounded end 18 of the obturator extends from the distal end of the tracheostomy tube 20. The proximal end of the guide tube 14 is threaded through the central opening 15 of the obturator 12 by means of the tip 18 and the entire obturator 12—tracheostomy tube 20 assembly is fed over the guide tube 14 so as to be guided into position through the existing opening in the trachea using guide tube 14 as a guide. The rounded tip 18 of the obturator serves to center the tracheostomy tube 20 within the tracheal lumen and to guide it into place atraumatically. Once the obturator tube 20 is secured in place, the obturator 12 and the guide tube 14 are removed from the tracheostomy tube 20. The cuff 30 is then inflated and its position verified in a routine manner. (Miles 4:24—54.) FF 24. Examiner relies on Theis to disclose “a neck plate [] that is movable along [a] shaft” (Ans. 8, citing Theis 2:5—16). ANALYSIS The combination of Crandall, Shelden, and Weinstein, with or without Toye: Based on the combination of Crandall, Shelden, and Weinstein, Examiner concludes that, at the time Appellants’ invention was made, it would have been prima facie obvious to: “modify the inner and outer cannula of Crandall to include beveled tapers as taught by Shelden to provide enhanced injury prevention and secure fit” and “provide the tracheal assembly of Crandall with a guide wire as taught by Weinstein to assist in guiding the tracheal tube shaft into the trachea as disclosed in [] Weinstein” (Ans. 3—4). In addition, based on the combination of Crandall, Shelden, 13 Appeal 2015-007300 Application 11/886,587 Weinstein, and Toye, Examiner concludes that, at the time Appellants’ invention was made, it would have been prima facie obvious “to modify the shaft of Crandall with the ultra-flexible shaft of Toye to provide additional comfort to a user” (Ans. 5). We are not persuaded. Appellant’s claim 9 requires, inter alia, “an outer, tubular shaft . . . and an introducer inserted within the shaft,” wherein “the introducer ha[s] a distal portion that is adapted to extend beyond the distal end of the shaft,” such that when the introducer is fully inserted into the shaft, the tapered distal portion of the introducer extends beyond the distal end of the shaft to provide a projecting, tapering nose that forms the tapered tip for the assembly for introducing and guiding the assembly through the tracheal tissue during insertion to the trachea. (App. Br. 27). Similarly, Appellant’s claim 16 requires, inter alia, a shaft having a distal end and a bore extending along the shaft, an introducer matingly fitted into the bore with a tapered distal portion extending beyond the distal end of the shaft toward a distal opening at the introducer that opens into a passage that extends along the length of the introducer, wherein “the tapered distal portion of the introducer including a tapering nose adapted to act as a tip for the assembly to assist in introducing the assembly through the tracheal tissue of a patient” (App. Br. 28). Crandall discloses that when an inner cannula is inserted into the bore of the outer cannula, the distal tip of the inner cannula “is flush with or [extends] slightly beyond the . . . distal end [] of the outer cannula” (FF 6). In this regard, Crandall discloses that if the inner cannula does extend past the distal tip of the outer cannula it “will extend only slightly, e.g., about 0.050 inches, beyond the end [] of the outer cannula” (FF 8). In addition, 14 Appeal 2015-007300 Application 11/886,587 Examiner recognizes that Crandall fails to suggest a tracheostomy tube assembly that comprises an inner cannula that is tapered at the distal end and relies on Shelden to make up for this deficiency in Crandall (FF 9). Shelden discloses a tracheotomy instrument that comprises both an outer and inner cannula, wherein both the outer and inner cannulas are tapered (FF 14). Shelden discloses that when the inner cannula is disposed within the outer cannula the distal tip of the inner cannula is “substantially flush” with the distal tip of the outer cannula (id. ). Thus, the combination of Crandall and Shelden suggests a device comprising distally tapered inner and outer cannulas that are flush with one another at the distal tip of the device or, in the alternative, a device wherein the inner cannula extends about 0.050 inches beyond the distal tip of the outer cannula. Examiner, however, failed to establish an evidentiary basis on this record to support a conclusion that even if the inner cannula, of the device suggested by the combination of Crandall and Shelden, extended about 0.050 inches beyond the outer cannula, the inner cannula would have been capable of performing the function of an introducer as required by Appellant’s claimed invention (see FF 1—14; cf. App. Br. 14—19 (asserting that the inner cannula disclosed by both Crandall and Shelden is not an introducer as that term is used in Appellant’s claims and Specification)). In this regard, Appellant contends that because the distal tip of the inner cannula preferably should be flush with the distal tip of the outer cannula and, at most extend only slightly from the distal tip of the outer cannula, clearly indicates that the inner cannula is not the means used to insert the tracheostomy tube of Crandall into the trachea of the patient. (App. Br. 12.) In addition, we recognize that, notwithstanding Examiner’s contention to the contrary, Shelden inserts the inner cannula into Shelden’s 15 Appeal 2015-007300 Application 11/886,587 outer cannula after the outer cannula is inserted into the trachea (FF 14). Thus, Shelden fails to suggest the use of Shelden’s inner cannula as an introducer that falls within the scope of Appellant’s claimed invention (see id.', cf. App. Br. 27 (Claim 9 require, inter alia, “after the [outer] shaft is properly located in the trachea of the patient, the introducer is removed rearwardly from the [outer] shaft so that the bore of the [outer] shaft is free to provide a gas passage to the trachea”); App. Br. 28 (“the introducer being removable rearwardly from the [outer] shaft so that the bore of the [outer] shaft is opened to provide a gas passage to the trachea after the [outer] shaft is properly located in the trachea of the patient”)). Examiner failed to establish that Weinstein alone, or in combination with Toye, makes up for the foregoing deficiency in the combination of Crandall and Shelden (see FF 15—16). In re Kahn, 441 F.3d 977, 988 (Fed. Cir. 2006) (“rejections on obviousness grounds cannot be sustained by mere conclusory statements; instead, there must be some articulated reasoning with some rational underpinning to support the legal conclusion of obviousness”). The combination of Miles and Crandall, with or without Toye, Theis, or Weinstein'. Based on the combination of Miles and Crandall, Examiner concludes that, at the time Appellants’ invention was made, it would have been prima facie obvious to provide the shaft and introducer of Miles with cooperating surface formations as taught by Crandall to provide a sealing surface to provide a stop against excessive displacement of the introducer past the shaft which would cause tracheal trauma and 16 Appeal 2015-007300 Application 11/886,587 to prevent the shaft from sliding rearward over the obturator for better placement. (Ans. 7.) In addition, Examiner concludes that, at the time Appellants’ invention was made, it would have been prima facie obvious to: “modify the shaft [suggested by the combination] of Miles [and Crandall] with the ultra-flexible shaft of Toye to provide additional comfort to a user;” “modify the neck plate [suggested by the combination] of Miles [and Crandall] with the axially moveable neck plate as taught by Theis to provide adjustments to adapt to the thickness of the neck of the patient as taught by Theis;” and “to provide the guide member [suggested by the combination] of [] Miles [and Crandall] with straight and curved sections as taught by Weinstein to provide enhanced curvature to facilitate passage into the trachea” (Ans. 8— 9). We are not persuaded. Miles discloses the use of an “obturator,” or introducer, to atraumatically introduce a tracheostomy tube into a patient (FF 17—23). In this regard, Miles discloses that both the obturator and tracheostomy tube comprise flanged proximal ends, wherein the flanged proximal end of the obturator abuts the flanged proximal end of the tracheostomy tube when the obturator is disposed inside the tracheostomy tube (see FF 21 and 23). As Appellant explains correctly, notwithstanding Examiner’s contention to the contrary, “it would not be obvious to a person skilled in the art to modify the Miles device as per the suggestion by the Examiner, as there is already means,” specifically, flanges 16 and 17 present on the tracheostomy tube and obturator respectively, that prevent rearward displacement of the tracheostomy tube along the obturator as they are inserted into a patient’s trachea (see App. Br. 23; FF 18, 19, and 21; see also Reply Br. 12 (Examiner [] failed to provide a reasonable explanation and/or motivation on 17 Appeal 2015-007300 Application 11/886,587 how Crandall and Miles could be combined in the manner as alleged by the Examiner”)). In addition, for the reasons discussed above, Examiner failed to establish an evidentiary basis on this record to support a conclusion that an inner cannula, as suggested by Crandall, which may extend about 0.050 inches beyond the distal tip of an outer cannula, such as Miles’ tracheostomy tube, would have been capable of performing the function of an introducer as required by Appellant’s claimed invention and/or an obturator as required by Miles’ disclosure (see e.g., FF 6, 8, and 17—23; see also Reply Br. 12— 13). Examiner further failed to establish that any of Toye, Theis, or Weinstein make up for the deficiencies in the combination of Miles and Crandall discussed above (see FF 15, 16, and 24). CONCFUSION OF FAW The preponderance of evidence relied upon by Examiner fails to support a conclusion of obviousness. The rejection of claims 9-11, 13—18, and 20—22 under 35 U.S.C. § 103(a) as unpatentable over the combination of Crandall, Shelden, and Weinstein is reversed. The rejection of claims 12 and 19 under 35 U.S.C. § 103(a) as unpatentable over the combination of Crandall, Shelden, Weinstein, and Toye is reversed. The rejection of claims 9-11, 13, 16—18, and 20 under 35 U.S.C. § 103(a) as unpatentable over the combination of Miles and Crandall is reversed. 18 Appeal 2015-007300 Application 11/886,587 The rejection of claims 12 and 19 under 35 U.S.C. § 103(a) as unpatentable over the combination of Miles, Crandall, and Toye is reversed. The rejection of claims 14 and 21 under 35 U.S.C. § 103(a) as unpatentable over the combination of Miles, Crandall, and Theis is reversed. The rejection of claims 15 and 22 under 35 U.S.C. § 103(a) as unpatentable over the combination of Miles, Crandall, and Weinstein is reversed. TIME PERIOD FOR RESPONSE No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED 19 Copy with citationCopy as parenthetical citation